A must read for today's afternoon presented today at #AACR25 by C. Curtis: beatiful through work on classical breast cancer subtypes characterization shows deep similarity between HER2+ and ER+ high risk www.nature.com/articles/s41...

Great talk on CAR NK potential by Katy Rezvani: potent citotoxicity, unexpected durable response. Amazing clinical trial pipeline at @mdanderson.bsky.social

Great work on CAR-T improvement by Marcela Maus: beyond IFNg KO, CRISPR screening libraries in vivo and in vitro to look for the best candidates #AACR25

Encouraging pre-clinical results for GBM patients: triple-comb (DXM + antiCSF1 + antiTGFB) inhibitis post RT scarring, a niche for tumor recurrence @johannajoyce.bsky.social #AACR25

Kickoff talk of first plenary session on genomic evolution, impressive work: from non tumoral to pre-malignant stages by @imartincorena.bsky.social Bioinformatics opening of #AACR25

A way to start with @bsky.app ! 7 days of cutting edge cancer research #AACR25